Overview
KALA market data
Price History
KALA price chart
Valuation & Profitability
- P/E (TTM)
- — Trailing twelve-month price-to-earnings ratio. Higher means the market is pricing in more growth. Negative or missing when earnings are negative.
- Forward P/E
- — P/E based on consensus forward EPS estimates. Lower versus trailing implies expected earnings growth.
- EPS (TTM)
- -$10.26 Diluted earnings per share over the trailing twelve months.
- Beta
- -2.37 Volatility relative to the index. 1.00 equals market, above 1 amplifies the broad-market move, below 1 dampens it.
- Dividend Yield
- — Annual dividend per share divided by current price. Zero or blank when the company does not pay a dividend.
- Profit Margin
- — Net income divided by revenue. Comparable within a sector, less so across sectors.
- 52w range
- $0.60 – $1,030.00 Lowest and highest closing prices over the past 52 weeks.
- Analyst Target
- — Mean of sell-side analyst 12-month price targets. Use as a sentiment gauge; targets are biased upward in aggregate.
Display-only. Refreshed once per symbol per 24 hours · source Twelve Data /statistics · market cap $11.3 · P/B 3.43 · P/S 1.97.
Company news
Kala Bio Files ATM Offering Of Up To $250M In Common StockBenzinga · Jul 22, 2026, 9:43 PM
Kala Bio Q1 EPS $(0.14) Beats $(0.30) EstimateBenzinga · May 15, 2026, 11:13 PM
Trading Halt: Halt status updated at 8:55:00 AM ET: Quotation Resumption: News and Resumption TimesBenzinga · May 11, 2026, 12:55 PM
8-K filing — KALA BIO, Inc. (KALA)SEC EDGAR · May 7, 2026, 8:07 PM